###begin article-title 0
###xml 68 89 68 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Haemophilus influenza</italic>
###xml 141 145 <span type="species:ncbi:10090">Mice</span>
Tumor Suppressor CYLD Acts as a Negative Regulator for Non-Typeable Haemophilus influenza-Induced Inflammation in the Middle Ear and Lung of Mice
###end article-title 0
###begin p 1
Conceived and designed the experiments: J-DL JHL. Performed the experiments: JHL HJ TK HI UH HX CW PB HX. Analyzed the data: JHL HJ TK HI UH HX CW PB HX. Contributed reagents/materials/analysis tools: J-DL. Wrote the paper: J-DL JHL.
###end p 1
###begin p 2
###xml 13 34 13 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Haemophilus influenza</italic>
###xml 523 531 515 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 614 621 606 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 728 735 720 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1076 1083 1060 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 58 63 <span type="species:ncbi:9606">human</span>
###xml 129 137 <span type="species:ncbi:9606">children</span>
###xml 422 427 <span type="species:ncbi:9606">human</span>
###xml 723 727 <span type="species:ncbi:10090">mice</span>
###xml 818 822 <span type="species:ncbi:10090">mice</span>
Non-typeable Haemophilus influenza (NTHi) is an important human pathogen causing respiratory tract infections in both adults and children. NTHi infections are characterized by inflammation, which is mainly mediated by nuclear transcription factor kappaB (NF-kappaB)-dependent production of inflammatory mediators. The deubiquitinating enzyme cylindromatosis (CYLD), loss of which was originally reported to cause a benign human syndrome called cylindromatosis, has been identified as a key negative regulator for NF-kappaB in vitro. However, little is known about the role of CYLD in bacteria-induced inflammation in vivo. Here, we provided direct evidence for the negative role of CYLD in NTHi-induced inflammation of the mice in vivo. Our data demonstrated that CYLD is induced by NTHi in the middle ear and lung of mice. NTHi-induced CYLD, in turn, negatively regulates NTHi-induced NF-kappaB activation through deubiquitinating TRAF6 and 7 and down-regulates inflammation. Our data thus indicate that CYLD acts as a negative regulator for NF-kappaB-dependent inflammation in vivo, hence protecting the host against detrimental inflammatory response to NTHi infection.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 12 34 12 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Haemophilus influenzae</italic>
###xml 129 132 129 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Foxwell1">[1]</xref>
###xml 326 329 326 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Rao1">[2]</xref>
###xml 330 333 330 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Murphy1">[4]</xref>
###xml 1008 1011 1004 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Murphy2">[5]</xref>
###xml 1012 1015 1008 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Ghosh1">[8]</xref>
###xml 1226 1229 1207 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Watanabe1">[6]</xref>
###xml 1231 1234 1212 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Shuto1">[9]</xref>
###xml 1236 1240 1217 1221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Imasato1">[10]</xref>
###xml 12 34 <span type="species:ncbi:727">Haemophilus influenzae</span>
###xml 36 40 <span type="species:ncbi:727">NTHi</span>
###xml 86 91 <span type="species:ncbi:9606">human</span>
###xml 120 128 <span type="species:ncbi:9606">children</span>
###xml 207 215 <span type="species:ncbi:9606">children</span>
###xml 419 423 <span type="species:ncbi:727">NTHi</span>
###xml 610 614 <span type="species:ncbi:727">NTHi</span>
###xml 722 726 <span type="species:ncbi:727">NTHi</span>
###xml 791 795 <span type="species:ncbi:727">NTHi</span>
###xml 846 850 <span type="species:ncbi:727">NTHi</span>
###xml 1047 1051 <span type="species:ncbi:727">NTHi</span>
###xml 1324 1328 <span type="species:ncbi:727">NTHi</span>
Nontypeable Haemophilus influenzae (NTHi), a gram-negative bacterium, is an important human pathogen in both adults and children [1]. In adults, it exacerbates chronic obstructive pulmonary diseases, and in children, it causes otitis media, the most common childhood infection and the leading cause of conductive hearing loss [2]-[4]. Despite the need for prophylactic measures, development of a vaccine for preventing NTHi infections has been difficult and still remains a great challenge. Moreover, inappropriate antibiotic treatment contributes to the worldwide emergence of antibiotic-resistant strains of NTHi. Therefore, there is an urgent need for developing alternative therapeutic strategies for the treatment of NTHi infections based on understanding the molecular pathogenesis of NTHi infections. Like most other bacterial infections, NTHi infection is characterized by inflammation, which is mainly mediated by nuclear factor kappaB (NF-kappaB)-dependent production of pro-inflammatory mediators [5]-[8]. We have previously shown that NTHi induces Toll-like receptor (TLR) 2-dependent activation of NF-kappaB via an IKKbeta-IkappaBalpha- and p38 mitogen-activated protein kinase (MAPK)-dependent signaling pathway [6], [9], [10]. However, the key signaling adaptors that link TLR2 with IKK and MAPK in mediating NTHi-induced inflammation remain unknown.
###end p 4
###begin p 5
###xml 202 206 202 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Ulevitch1">[11]</xref>
###xml 208 212 208 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-KurtJones1">[12]</xref>
###xml 912 916 <span type="species:ncbi:727">NTHi</span>
###xml 1178 1182 <span type="species:ncbi:727">NTHi</span>
Although the inflammatory response triggered by bacteria is essential for eradicating bacterial pathogen, excessive inflammatory response is clearly detrimental to the host, due to severe tissue damage [11], [12]. To avoid overactive and detrimental inflammatory response in infectious disease, the bacteria-induced inflammatory response must be tightly regulated. During evolution, the host has developed a variety of strategies to prevent detrimental inflammatory response during bacterial infections. Among all strategies, bacteria-induced negative feedback regulation is thought to play a critical role in preventing overactive inflammatory response by tightly regulating the activity of the key receptor-dependent signaling adaptors specifically activated by bacterial pathogens. In the pathogenesis of chronic obstructive pulmonary diseases and otitis media, to avoid detrimental inflammatory responses in NTHi infection, TLR2 signaling must be tightly regulated. However, despite the importance of tight regulation in preventing overactive inflammatory response, the molecular mechanisms underlying the negative feedback regulation of inflammation in the pathogenesis of NTHi infection remain unknown.
###end p 5
###begin p 6
###xml 122 126 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Bignell1">[13]</xref>
###xml 127 131 127 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-PobleteGutierrez1">[15]</xref>
###xml 133 141 133 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 453 457 449 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Trompouki1">[16]</xref>
###xml 458 462 454 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Kovalenko1">[18]</xref>
###xml 583 587 579 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Reiley1">[19]</xref>
###xml 588 592 584 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Reiley2">[22]</xref>
###xml 668 672 660 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Yoshida1">[20]</xref>
###xml 674 678 666 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Jono1">[23]</xref>
###xml 1069 1076 1049 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1210 1217 1190 1197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1292 1299 1272 1279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 84 89 <span type="species:ncbi:9606">human</span>
###xml 1064 1068 <span type="species:ncbi:727">NTHi</span>
CYLD was originally identified as a tumor suppressor, loss of which causes a benign human syndrome called cylindromatosis [13]-[15]. In vitro studies have indicated that CYLD is a member of the deubiquitinating enzyme family that specifically digests polyubiquitin chains. Transfection studies showed that CYLD deubiquitinates TRAF2 and TRAF6 and acts as a negative regulator for activation of NF-kappaB by tumor necrosis factor receptor (TNFR) and TLR [16]-[18]. Recently, we, together with others, showed that CYLD also negatively regulates activation of MAPKs, including p38 MAPK [19]-[22]. Moreover, the expression of CYLD is itself under the control of NF-kappaB [20], [23], suggesting that CYLD is involved in a negative feedback regulation of NF-kappaB activation and NF-kappaB-dependent gene expression. Given the important role that NF-kappaB plays in host immune and inflammatory response in bacteria infection, it is logical to hypothesize that CYLD may act as a negative regulator for immune and inflammatory response against invading bacteria such as NTHi in vivo. However, despite recent studies demonstrating the role of CYLD in regulating T cell receptor signaling and tumor cell proliferation in vivo, the biological role of CYLD especially its negative role in inflammation in vivo still remains unknown.
###end p 6
###begin p 7
###xml 99 103 99 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyld</italic>
###xml 131 138 131 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 31 35 <span type="species:ncbi:727">NTHi</span>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
###xml 153 157 <span type="species:ncbi:727">NTHi</span>
###xml 333 337 <span type="species:ncbi:727">NTHi</span>
In the present study, by using NTHi-induced otitis media and pneumonia model in wild type (WT) and Cyld-deficient mice, we provide in vivo evidence that NTHi induces pro-inflammatory response through TLR2-dependent MyD88-TRAF6/7-NF-kappaB signaling pathway, and CYLD negatively regulates NF-kappaB-dependent inflammatory response by NTHi via deubiquitination of TRAF6 and TRAF7. These studies may lead to development of novel therapeutic strategies for controlling overactive inflammatory response in respiratory bacterial infections.
###end p 7
###begin title 8
Materials and Methods
###end title 8
###begin title 9
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 9
###begin p 10
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyld<sup>&#8722;/&#8722;</sup></italic>
###xml 79 83 79 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Zhang1">[21]</xref>
###xml 87 91 87 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyld</italic>
###xml 574 578 574 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyld</italic>
###xml 845 848 845 848 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 841 848 841 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tlr2<sup>&#8722;/&#8722;</sup></italic>
###xml 858 861 858 861 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 853 861 853 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MyD88<sup>+/&#8722;</sup></italic>
###xml 888 892 888 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Takeuchi1">[24]</xref>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 548 552 <span type="species:ncbi:10090">mice</span>
Cyld-/- mice were generated by homologous recombination as previously reported [21]. A Cyld-gene targeting construct was designed to delete exons 2 and 3 and replace them with a lacZ reporter and a neomycin resistance gene. The targeting vector was linearized and electroporated into 129S ES cells. Clones resistant to G417 were selected and screened for homologous recombinants by Southern blot analysis. Two targeted ES cell clones were microinjected into C57BL/6 blastocysts, and the resulting chimeras were mated to C57BL/6 females to generate mice heterozygous for the Cyld mutation. Homozygous knockout animals were obtained by mating of heterozygous males and females. Genotyping was performed by PCR on tail-derived genomic DNA, and absence of RNA transcript and protein expression was confirmed by RT-PCR and Western blot analysis. Tlr2-/- and MyD88+/- were described previously [24].
###end p 10
###begin title 11
Animal experiments
###end title 11
###begin p 12
###xml 50 53 50 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 46 53 46 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyld<sup>&#8722;/&#8722;</sup></italic>
###xml 122 123 122 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 683 687 683 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Yoshida1">[20]</xref>
###xml 4 8 <span type="species:ncbi:727">NTHi</span>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 131 135 <span type="species:ncbi:727">NTHi</span>
###xml 220 224 <span type="species:ncbi:10090">mice</span>
###xml 366 370 <span type="species:ncbi:727">NTHi</span>
###xml 540 544 <span type="species:ncbi:727">NTHi</span>
###xml 1196 1200 <span type="species:ncbi:727">NTHi</span>
###xml 1283 1287 <span type="species:ncbi:727">NTHi</span>
For NTHi-induced otitis media model in WT and Cyld-/- mice, anaesthetized mice were transtympanically inoculated with 1x107 CFU of NTHi under the surgical microscope, and saline was inoculated as control. The inoculated mice were then sacrificed by intraperitoneal inoculation of 100 mg/kg sodium pentobarbital at 3, 6, 9, 24, 72, and 168 hours after inoculation of NTHi. Eardrum was inspected under the otoscope and findings were recorded. To assess the mRNA expression of inflammatory mediators, total RNA was extracted from the bulla of NTHi and saline-inoculated ear at the time points indicated above and real-time quantitative PCR (Q-PCR) was performed as described previously [20]. For histological analysis, dissected temporal bones were fixed with 10% buffered formaldehyde overnight with rocking, decalcified with CalEX, embedded in paraffin, and sectioned at 5-microM thickness. Sections were then stained with hematoxylin and eosin (H&E) to visualize inflammatory response and pathological changes in the middle ear. H&E-stained middle ear sections were then evaluated by light microscopy using Axiovert 40 CFL (Carl Zeiss), and images were recorded with an AxioCam MRC (Carl Zeiss). NTHi culture positivity was confirmed by bacterial culture of middle ear effusion from NTHi-inoculated ears.
###end p 12
###begin p 13
###xml 47 50 47 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 56 59 56 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 43 60 43 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyld<sup>&#8722;/&#8722;</sup>, Tlr2<sup>&#8722;/&#8722;</sup>,</italic>
###xml 70 73 70 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 65 73 65 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MyD88<sup>+/&#8722;</sup></italic>
###xml 140 141 140 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 1017 1021 1013 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Yoshida1">[20]</xref>
###xml 4 8 <span type="species:ncbi:727">NTHi</span>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
###xml 149 153 <span type="species:ncbi:727">NTHi</span>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 902 906 <span type="species:ncbi:727">NTHi</span>
For NTHi-induced pneumonia model in WT and Cyld-/-, Tlr2-/-, and MyD88+/- mice, anaesthetized mice were intratracheally inoculated with 5x107 CFU of NTHi, and saline was inoculated as control. The inoculated mice were then sacrificed by intraperitoneal inoculation of 100 mg/kg sodium pentobarbital at the time points indicated above. For histological analysis, dissected lung was inflated and fixed with 10% buffered formaldehyde, embedded in paraffin, and sectioned at 5-microM thickness. Sections were then stained and inspected as described above. For polymorphonuclear neutrophil (PMN) analysis, bronchoalveolar lavage (BAL) was performed by cannulating the trachea with sterilized PBS. Cells from BAL fluid were stained with Hemacolor (EM Science) after cytocentrifugation (Thermo Electronic Co.). To assess the mRNA expression of inflammatory mediators, total RNA was extracted from the lung of NTHi and saline-inoculated lung at the time points indicated above and Q-PCR was performed as described previously [20]. All animal experiments were approved by the Institutional Animal Care and Use Committee at University of Rochester.
###end p 13
###begin title 14
Bacteria strain and culture
###end title 14
###begin p 15
###xml 57 65 57 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 95 102 95 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 122 125 122 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Shuto1">[9]</xref>
###xml 203 204 197 198 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 536 544 526 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 589 596 579 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 621 629 611 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 768 775 758 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 912 913 902 903 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 930 931 920 921 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 20 24 <span type="species:ncbi:727">NTHi</span>
###xml 409 413 <span type="species:ncbi:727">NTHi</span>
###xml 682 686 <span type="species:ncbi:727">NTHi</span>
###xml 796 800 <span type="species:ncbi:727">NTHi</span>
Clinical isolate of NTHi wild-type strain 12 was used in in vitro cell culture experiments and in vivo animal experiments [9]. Bacteria was grown on chocolate agar at 37degreesC in an atmosphere of 5% CO2 for overnight and inoculated in brain heart infusion broth supplemented with 3.5 microg of NAD per ml (BHI). After overnight incubation, bacteria were subcultured into 5 ml of fresh BHI and the log phase NTHi that was monitored by measurement of optical density (OD) value was washed and suspended in phosphate-buffered saline for in vitro cell experiments and in isotonic saline for in vivo animal experiments. For in vitro experiments, the epithelial cells were treated with NTHi at a multiplicity of infection (MOI) of 1:25 for various times as indicated. For in vivo animal experiments, NTHi was inoculated into the middle ear for otitis media model and the lung for pneumonia at a concentration of 1x107 CFU/ear and 5x107 CFU/lung, respectively.
###end p 15
###begin title 16
Cell culture
###end title 16
###begin p 17
###xml 323 326 323 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Watanabe1">[6]</xref>
###xml 328 331 328 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Shuto1">[9]</xref>
###xml 333 337 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Kweon1">[25]</xref>
###xml 400 403 400 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Shuto1">[9]</xref>
###xml 405 409 405 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Sakai1">[26]</xref>
###xml 587 590 587 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Watanabe1">[6]</xref>
###xml 592 596 592 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Jono1">[23]</xref>
###xml 598 602 598 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Kweon1">[25]</xref>
###xml 687 691 687 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Kim1">[27]</xref>
###xml 733 734 733 734 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 743 744 743 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1380 1381 1376 1377 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 100 105 <span type="species:ncbi:9606">human</span>
###xml 149 154 <span type="species:ncbi:9606">human</span>
###xml 426 431 <span type="species:ncbi:9606">human</span>
Human middle ear epithelial cell line HMEEC-1, a commonly used middle ear cell line, was derived by human papilloma virus immortalization of primary human middle ear epithelial cells, and was maintained in a 1:1 mixutre of Bronchial Epithelial Basal Medium (BEBM) and Dulbecco's modified Eagle's medium (DMEM) as described [6], [9], [25]. Airway epithelial cell line A549 was maintained as described [9], [26]. Primary normal human bronchial epithelial cell (NHBE) were purchased from Cambrex and were maintained as described previously in Bronchial Epithelial cell Growth Medium (BEGM) [6], [23], [25]. For air-liquid interface culture, NHBE cells were cultured as described previously [27]. In brief, NHBE cells were seeded at 2x104 cells/cm2 onto 24-mm-diameter, 0.4 microm pore size, semi-permeable membrane inserts (Corning) in BEBM. The cultures were grown submerged for the first 7 days and then, the air-liquid interface was created by removing media from the apical compartment of the cultures. The culture media were changed every other day until the air-liquid interface was created and were changed daily by replacing fresh media only to the basal compartment during the air-liquid interface culture. NHBE cells were grown in air-liquid interface for 2-3 weeks before being used for the proposed experiments. All cells were cultured in a humidified atmosphere of 5% CO2 and 95% air at 37degreesC.
###end p 17
###begin title 18
Transfection and Small Interfering RNA (siRNA)
###end title 18
###begin p 19
###xml 116 119 112 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Watanabe1">[6]</xref>
###xml 121 124 117 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Shuto1">[9]</xref>
###xml 126 130 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Yoshida1">[20]</xref>
###xml 132 136 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Jono1">[23]</xref>
###xml 138 142 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Kweon1">[25]</xref>
###xml 878 882 870 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Yoshida1">[20]</xref>
###xml 884 888 876 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Jono1">[23]</xref>
###xml 668 672 <span type="species:ncbi:727">NTHi</span>
The plasmids TLR2, MyD88, TRAF6, and TRAF7 DN, WT CYLD, and NF-kappaB-luciferase reporter were described previously [6], [9], [20], [23], [25]. Cells were cultured on 24-well plates. After 24 hours, cells were co-transfected with or without NF-kappaB-luciferase reporter plasmid and various expression plasmids as indicated in the figure legends. Empty vector was used as a control and was added where necessary to ensure a constant amount of input DNA. All transient transfections were carried out in triplicate using a TransIT-LT1 reagent (Mirus Co.) following the manufacturer's instructions. At 40 hours after the start of transfection, cells were inoculated with NTHi for 5 hours before cell lysis for luciferase assay or mRNA analysis as described previously. RNA-mediated interference for down-regulating CYLD expression was done using siRNA-CYLD as described previously [20], [23].
###end p 19
###begin title 20
Western blot (WB) analysis and immunoprecipitation (IP)
###end title 20
###begin p 21
Antibodies against TRAF6, HA and Ubiquitin were purchased from Santa Cruz Biotechnology, and CYLD was from IMGENEX.
###end p 21
###begin p 22
###xml 42 46 42 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Yoshida1">[20]</xref>
###xml 48 52 48 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Jono1">[23]</xref>
Western blots were performed as described [20], [23] and following the manufacturer's instruction. Briefly, Western blots were performed using whole cell extracts, separated on 8-10% SDS-PAGE gels, and transferred to poly-vinylidine difluoride membranes. The membrane was blocked with 5% nonfat milk, incubated in a 1:2,000 dilution of a primary antibody, and incubated with 1:2,000 dilution of the corresponding secondary antibody. The membrane was reacted with chemiluminescence reagent ECL to visualize to blots. For immunoprecipitation, cell lysates were immunoprecipitated with 1 microg of the appropriate antibodies for overnight at 4degreesC and then conjugated to protein A/G-agarose beads for 2 hours at 4degreesC.
###end p 22
###begin title 23
Statistical analysis
###end title 23
###begin p 24
###xml 54 60 54 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p&lt;0.05</italic>
Data were analyzed using Student's t-test. A value of p<0.05 was considered significant.
###end p 24
###begin title 25
Results
###end title 25
###begin title 26
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyld<sup>&#8722;/&#8722;</sup></italic>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 36 40 <span type="species:ncbi:727">NTHi</span>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
Cyld-/- mice are hyperresponsive to NTHi-induced inflammation in the ear and lung of the mice
###end title 26
###begin p 27
###xml 68 75 68 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 77 81 77 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyld</italic>
###xml 174 178 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Zhang1">[21]</xref>
###xml 193 196 193 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 189 196 189 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyld<sup>&#8722;/&#8722;</sup></italic>
###xml 247 251 247 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyld</italic>
###xml 425 429 425 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyld</italic>
###xml 449 452 449 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 445 452 445 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyld<sup>&#8722;/&#8722;</sup></italic>
###xml 557 561 557 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyld</italic>
###xml 574 578 574 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyld</italic>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 378 382 <span type="species:ncbi:10090">mice</span>
###xml 453 457 <span type="species:ncbi:10090">mice</span>
###xml 486 491 <span type="species:ncbi:10090">mouse</span>
###xml 589 593 <span type="species:ncbi:10090">mice</span>
To determine the biological role of CYLD in regulating inflammation in vivo, Cyld-deficient mice were generated by using standard targeting technique as described previously [21]. Briefly, Cyld-/- mice were generated by replacing exons 2 and 3 of Cyld gene with a neomycin resistance-lacZ cassette. Homozygous mutant was ascertained by PCR genotyping from tail tissue of mutant mice. RT-PCR analysis confirmed the absence of Cyld transcripts in Cyld-/- mice, and immunoblot analysis of mouse embryonic fibroblast (MEF) using an antibody against CYLD showed Cyld deficiency. Cyld-deficient mice exhibit no overt abnormalities and have a normal lifespan.
###end p 27
###begin p 28
###xml 129 132 129 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 125 132 125 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyld<sup>&#8722;/&#8722;</sup></italic>
###xml 171 174 171 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 167 174 167 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyld<sup>&#8722;/&#8722;</sup></italic>
###xml 437 440 437 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 433 440 433 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyld<sup>&#8722;/&#8722;</sup></italic>
###xml 469 476 469 476 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1A</bold>
###xml 469 476 469 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001032-g001"><bold>Fig. 1A</bold></xref>
###xml 653 656 653 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 649 656 649 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyld<sup>&#8722;/&#8722;</sup></italic>
###xml 685 692 685 692 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1B</bold>
###xml 685 692 685 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001032-g001"><bold>Fig. 1B</bold></xref>
###xml 80 84 <span type="species:ncbi:727">NTHi</span>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
###xml 201 205 <span type="species:ncbi:727">NTHi</span>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
###xml 441 445 <span type="species:ncbi:10090">mice</span>
###xml 463 467 <span type="species:ncbi:10090">mice</span>
###xml 547 551 <span type="species:ncbi:727">NTHi</span>
###xml 563 567 <span type="species:ncbi:10090">mice</span>
###xml 657 661 <span type="species:ncbi:10090">mice</span>
###xml 679 683 <span type="species:ncbi:10090">mice</span>
We next investigated the negative role of CYLD in inflammatory response against NTHi infection in the middle ear and lung of Cyld-/- mice. Age- and sex-matched WT and Cyld-/- mice were inoculated with NTHi and inflammatory response in the middle ear and lung of infected mice was monitored up to 7 days. Histological examination of the middle ear revealed enhanced inflammatory responses including enhanced leukocyte infiltration in Cyld-/- mice compared with WT mice (Fig. 1A). Consistent with this result, histological evaluation of the lung of NTHi-inoculated mice showed enhanced leukocyte infiltration in peribroncheal and interstitial area in Cyld-/- mice compared with WT mice (Fig. 1B).
###end p 28
###begin title 29
###xml 5 8 5 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> Cyld<sup>&#8722;/&#8722;</sup></italic>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
###xml 37 41 <span type="species:ncbi:727">NTHi</span>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
 Cyld-/- mice are hyperresponsive to NTHi-induced inflammation in the ear and lung of the mice.
###end title 29
###begin p 30
###xml 77 80 77 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 73 80 73 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyld<sup>&#8722;/&#8722;</sup></italic>
###xml 129 132 129 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 125 132 125 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyld<sup>&#8722;/&#8722;</sup></italic>
###xml 299 302 299 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 295 302 295 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyld<sup>&#8722;/&#8722;</sup></italic>
###xml 356 359 356 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 352 359 352 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyld<sup>&#8722;/&#8722;</sup></italic>
###xml 596 599 596 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 592 599 592 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyld<sup>&#8722;/&#8722;</sup></italic>
###xml 708 715 705 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p&lt;0.005</italic>
###xml 764 770 761 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p&lt;0.05</italic>
###xml 849 852 844 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CON</italic>
###xml 3 7 <span type="species:ncbi:727">NTHi</span>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
###xml 154 158 <span type="species:ncbi:727">NTHi</span>
###xml 234 238 <span type="species:ncbi:727">NTHi</span>
###xml 303 307 <span type="species:ncbi:10090">mice</span>
###xml 360 364 <span type="species:ncbi:10090">mice</span>
###xml 381 385 <span type="species:ncbi:727">NTHi</span>
###xml 465 469 <span type="species:ncbi:727">NTHi</span>
###xml 600 604 <span type="species:ncbi:10090">mice</span>
###xml 756 760 <span type="species:ncbi:10090">mice</span>
###xml 785 789 <span type="species:ncbi:727">NTHi</span>
###xml 808 812 <span type="species:ncbi:10090">mice</span>
A, NTHi was trans-tympanically inoculated into the middle ears of WT and Cyld-/- mice and bullaes were dissected from WT and Cyld-/- mice inoculated with NTHi and saline for the control for histological analysis (H&E stain, 200X). B, NTHi was intratracheally inoculated into the lungs of WT and Cyld-/- mice and lung tissues were dissected from WT and Cyld-/- mice inoculated with NTHi and saline for the control for histological analysis (H&E stain, 200x). C & D, NTHi was trans-tympanically (C) or intratracheally (D) inoculated into the middle ear (C) or lung (D), respectively, of WT and Cyld-/- mice and mRNA expression of the inflammatory mediators, IL-1beta and MIP-2, was measured by Q-PCR analysis *p<0.005 compared with control inoculation in WT mice, **p<0.05 compared with NTHi inoculation in WT mice. Values are means +/- S.D. (n = 3). CON, control.
###end p 30
###begin p 31
###xml 135 138 132 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Murphy2">[5]</xref>
###xml 140 143 137 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Watanabe1">[6]</xref>
###xml 258 261 252 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 254 261 248 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyld<sup>&#8722;/&#8722;</sup></italic>
###xml 326 329 320 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 322 329 316 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyld<sup>&#8722;/&#8722;</sup></italic>
###xml 413 420 404 411 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1C</bold>
###xml 413 420 404 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001032-g001"><bold>Fig. 1C</bold></xref>
###xml 439 446 430 437 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1D</bold>
###xml 439 446 430 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001032-g001"><bold>Fig. 1D</bold></xref>
###xml 548 551 535 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 544 551 531 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyld<sup>&#8722;/&#8722;</sup></italic>
###xml 695 702 682 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 0 4 <span type="species:ncbi:727">NTHi</span>
###xml 262 266 <span type="species:ncbi:10090">mice</span>
###xml 281 285 <span type="species:ncbi:727">NTHi</span>
###xml 316 320 <span type="species:ncbi:10090">mice</span>
###xml 330 334 <span type="species:ncbi:10090">mice</span>
###xml 552 556 <span type="species:ncbi:10090">mice</span>
###xml 660 664 <span type="species:ncbi:727">NTHi</span>
NTHi-induced inflammatory response and leukocyte infiltration are mediated by pro-inflammatory mediators, including IL-1beta and MIP-2 [5], [6]. Thus we measured expression of IL-1beta and MIP-2 at mRNA levels in the middle ear and lung from both WT and Cyld-/- mice 9 hours after NTHi inoculation. Compared with WT mice, Cyld-/- mice showed higher levels of IL-1beta and MIP-2 mRNA expression in the middle ear (Fig. 1C) and in the lung (Fig. 1D). In addition, we also found significant increases in the levels of TNF-alpha mRNA expression in Cyld-/- mice (data not shown). These results demonstrate that CYLD plays an important role in negatively regulating NTHi-induced inflammatory response in vivo.
###end p 31
###begin title 32
###xml 0 4 <span type="species:ncbi:727">NTHi</span>
NTHi-induced CYLD is responsible for down-regulation of inflammatory response
###end title 32
###begin p 33
###xml 148 152 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Dunne1">[28]</xref>
###xml 153 157 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Beutler1">[30]</xref>
###xml 293 297 293 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Bignell1">[13]</xref>
###xml 343 347 343 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Yoshida1">[20]</xref>
###xml 349 353 349 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Jono1">[23]</xref>
###xml 682 689 682 689 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2A</bold>
###xml 682 689 682 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001032-g002"><bold>Fig. 2A</bold></xref>
###xml 874 881 874 881 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2B</bold>
###xml 874 881 874 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001032-g002"><bold>Fig. 2B</bold></xref>
###xml 1204 1211 1204 1211 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2C</bold>
###xml 1204 1211 1204 1211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001032-g002"><bold>Fig. 2C</bold></xref>
###xml 1540 1551 1537 1548 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2D &amp; E</bold>
###xml 1540 1551 1537 1548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001032-g002"><bold>Fig. 2D &amp; E</bold></xref>
###xml 395 399 <span type="species:ncbi:727">NTHi</span>
###xml 465 469 <span type="species:ncbi:727">NTHi</span>
###xml 645 649 <span type="species:ncbi:727">NTHi</span>
###xml 691 695 <span type="species:ncbi:727">NTHi</span>
###xml 792 796 <span type="species:ncbi:727">NTHi</span>
###xml 920 925 <span type="species:ncbi:9606">human</span>
###xml 960 965 <span type="species:ncbi:9606">human</span>
###xml 1135 1139 <span type="species:ncbi:727">NTHi</span>
###xml 1179 1183 <span type="species:ncbi:727">NTHi</span>
###xml 1198 1202 <span type="species:ncbi:10090">mice</span>
###xml 1242 1246 <span type="species:ncbi:727">NTHi</span>
###xml 1404 1408 <span type="species:ncbi:727">NTHi</span>
###xml 1438 1442 <span type="species:ncbi:727">NTHi</span>
###xml 1457 1461 <span type="species:ncbi:10090">mice</span>
###xml 1709 1713 <span type="species:ncbi:727">NTHi</span>
It is well known that a variety of genes involved in inflammatory response undergo changes in expression pattern in response to bacterial infection [28]-[30]. We recently found that the endogenous expression level of CYLD is relatively low in middle ear and lung under physiological condition [13], but highly inducible by bacterial pathogens [20], [23], we hypothesized that CYLD is induced by NTHi and increased CYLD expression will in turn lead to inhibition of NTHi-induced inflammatory response, thereby preventing overactive inflammatory response that is detrimental to the host. We tested our hypothesis by first evaluating the effect of NTHi on CYLD expression. As shown in Fig. 2A, NTHi induced CYLD expression at the mRNA level in middle ear HMEEC-1 cells. The induction of CYLD by NTHi was also confirmed at the protein level by performing Western blot analysis (Fig. 2B). Similar result was also observed in human airway A549 cells and the primary human airway epithelial cells cultured under both regular liquid culture and physiological air-liquid interface condition (Data not shown). Moreover, up-regulation of CYLD by NTHi was also observed in the middle ear of NTHi-inoculated WT mice (Fig. 2C). Marked induction of CYLD by NTHi was observed at 6-9 hours, and an even greater induction of CYLD was still observed at 3-7 days. Consistent with these findings, marked induction of CYLD by NTHi was observed in the lungs of NTHi-inoculated WT mice along with down-regulation of pro-inflammatory mediators, IL-1beta and MIP-2 (Fig. 2D & E). It is interesting to note that the peak of CYLD induction was clearly preceded by the peak of the induction of IL-1beta and MIP-2, thereby suggesting that NTHi-induced CYLD is responsible for down-regulation of inflammatory response.
###end p 33
###begin title 34
###xml 0 4 <span type="species:ncbi:727">NTHi</span>
NTHi-induced CYLD is responsible for down-regulation of inflammatory response.
###end title 34
###begin p 35
###xml 286 292 283 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p&lt;0.05</italic>
###xml 347 350 342 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CON</italic>
###xml 7 11 <span type="species:ncbi:727">NTHi</span>
###xml 97 101 <span type="species:ncbi:727">NTHi</span>
###xml 168 172 <span type="species:ncbi:10090">mice</span>
###xml 181 185 <span type="species:ncbi:727">NTHi</span>
###xml 279 283 <span type="species:ncbi:10090">mice</span>
A & B, NTHi induced CYLD expression at both mRNA (A) and protein levels (B) in HMEEC-1 cells. C, NTHi induced CYLD expression at the mRNA level in the middle ear of WT mice. D & E, NTHi induced expression of CYLD and IL-1beta (D) or MIP-2 (E) at the mRNA level in the lung of WT mice. *p<0.05 compared with CON. Values are means +/- S.D. (n = 3). CON, control.
###end p 35
###begin title 36
###xml 0 4 <span type="species:ncbi:727">NTHi</span>
NTHi induces inflammatory response through TLR2-MyD88-TRAF6/7-NF-kappaB signaling pathway
###end title 36
###begin p 37
###xml 257 264 257 264 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3A</bold>
###xml 257 264 257 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001032-g003"><bold>Fig. 3A</bold></xref>
###xml 752 759 745 752 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3B</bold>
###xml 752 759 745 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001032-g003"><bold>Fig. 3B</bold></xref>
###xml 784 792 777 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 807 810 800 803 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 803 810 796 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tlr2<sup>&#8722;/&#8722;</sup></italic>
###xml 937 944 927 934 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3C</bold>
###xml 937 944 927 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001032-g003"><bold>Fig. 3C</bold></xref>
###xml 983 986 973 976 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 978 986 968 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MyD88<sup>+/&#8722;</sup></italic>
###xml 993 1000 983 990 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3D</bold>
###xml 993 1000 983 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001032-g003"><bold>Fig. 3D</bold></xref>
###xml 1123 1126 1113 1116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1119 1126 1109 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tlr2<sup>&#8722;/&#8722;</sup></italic>
###xml 1155 1162 1145 1152 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3E</bold>
###xml 1155 1162 1145 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001032-g003"><bold>Fig. 3E</bold></xref>
###xml 1327 1335 1313 1321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1340 1347 1326 1333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 81 85 <span type="species:ncbi:727">NTHi</span>
###xml 218 222 <span type="species:ncbi:727">NTHi</span>
###xml 417 421 <span type="species:ncbi:727">NTHi</span>
###xml 425 430 <span type="species:ncbi:9606">human</span>
###xml 495 500 <span type="species:ncbi:9606">human</span>
###xml 534 539 <span type="species:ncbi:9606">human</span>
###xml 689 693 <span type="species:ncbi:727">NTHi</span>
###xml 811 815 <span type="species:ncbi:10090">mice</span>
###xml 889 893 <span type="species:ncbi:10090">mice</span>
###xml 931 935 <span type="species:ncbi:727">NTHi</span>
###xml 987 991 <span type="species:ncbi:10090">mice</span>
###xml 1047 1051 <span type="species:ncbi:727">NTHi</span>
###xml 1063 1067 <span type="species:ncbi:10090">mice</span>
###xml 1127 1131 <span type="species:ncbi:10090">mice</span>
###xml 1149 1153 <span type="species:ncbi:10090">mice</span>
###xml 1272 1276 <span type="species:ncbi:727">NTHi</span>
We next sought to identify the molecular target of CYLD in negatively regulating NTHi-induced inflammation. We first examined if TLR2-MyD88 and TRAFs, a family of adaptor proteins, are critically involved in mediating NTHi-induced inflammation. As shown in Fig. 3A, overexpressing dominant-negative mutants of TLR2, MyD88 or TRAF6 or TRAF7, a newly identified member of TRAF family, inhibited NF-kappaB activation by NTHi in human middle ear HMEEC-1 cells. Similar results were also observed in human airway epithelial A549 cells and human primary bronchial epithelial NHBE cells (Data not shown). Moreover, overexpressing dominant-negative mutants of MyD88, TRAF6 or TRAF7 also inhibited NTHi-induced expression of IL-1beta and IL-8 in HMEEC-1 cells (Fig. 3B). Consistent with these in vitro findings, Tlr2-/- mice showed significant reduction in both IL-1beta and MIP-2 expression, when mice were intratracheally inoculated with NTHi (Fig. 3C). Similar result was observed in MyD88+/- mice (Fig. 3D). Moreover, histological analysis of lungs of NTHi-inoculated mice revealed markedly reduced inflammatory response in Tlr2-/- mice compared with WT mice (Fig. 3E). Thus, it is evident that TLR2-dependent MyD88-TRAF6/7 signaling pathway plays a critical role in mediating NTHi-induced NF-kappaB-dependent inflammatory response in vitro and in vivo.
###end p 37
###begin title 38
###xml 0 4 <span type="species:ncbi:727">NTHi</span>
NTHi induces inflammatory response through TLR2-MyD88-TRAF6/7-NF-kappaB signaling pathway.
###end title 38
###begin p 39
###xml 193 200 186 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p&lt;0.001</italic>
###xml 344 347 332 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 340 347 328 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tlr2<sup>&#8722;/&#8722;</sup></italic>
###xml 353 360 341 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 363 370 351 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p&lt;0.005</italic>
###xml 404 410 392 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p&lt;0.05</italic>
###xml 572 575 555 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 567 575 550 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MyD88<sup>+/&#8722;</sup></italic>
###xml 581 588 564 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 630 633 613 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 626 633 609 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tlr2<sup>&#8722;/&#8722;</sup></italic>
###xml 90 94 <span type="species:ncbi:727">NTHi</span>
###xml 260 264 <span type="species:ncbi:727">NTHi</span>
###xml 348 352 <span type="species:ncbi:10090">mice</span>
###xml 396 400 <span type="species:ncbi:10090">mice</span>
###xml 425 429 <span type="species:ncbi:727">NTHi</span>
###xml 448 452 <span type="species:ncbi:10090">mice</span>
###xml 492 496 <span type="species:ncbi:727">NTHi</span>
###xml 576 580 <span type="species:ncbi:10090">mice</span>
###xml 634 638 <span type="species:ncbi:10090">mice</span>
###xml 681 685 <span type="species:ncbi:727">NTHi</span>
###xml 703 707 <span type="species:ncbi:10090">mice</span>
A & B, Overexpressing dominant-negative (DN) mutants of TLR2, MyD88 and TRAF6/7 inhibited NTHi-induced activation of NF-kappaB (A) and up-regulation of IL-1beta and IL-8 (B) in HMEEC-1 cells. *p<0.001, compared with Mock. Values are means +/- S.D. (n = 3). C, NTHi-induced expressions of IL-1beta and MIP-2 mRNA were reduced in the lung of Tlr2-/- mice in vivo. *p<0.005, compared with CON in WT mice, **p<0.05 compared with NTHi inoculation in WT mice. Values are means +/- S.D. (n = 3). D, NTHi-induced expressions of IL-1beta and MIP-2 were reduced in the lung of MyD88+/- mice in vivo. E, Histological analysis of lung of Tlr2-/- mice revealed reduced inflammatory response by NTHi compared with WT mice (H&E stain, x200).
###end p 39
###begin title 40
###xml 38 42 <span type="species:ncbi:727">NTHi</span>
CYLD acts as a negative regulator for NTHi-induced NF-kappaB activation via negative cross-talk with TRAF6/7
###end title 40
###begin p 41
###xml 603 610 591 598 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4A</bold>
###xml 603 610 591 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001032-g004"><bold>Fig. 4A</bold></xref>
###xml 610 623 598 611 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">, upper panel</bold>
###xml 751 758 735 742 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4A</bold>
###xml 751 758 735 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001032-g004"><bold>Fig. 4A</bold></xref>
###xml 758 774 742 758 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">, lower panel &amp; </bold>
###xml 774 781 758 765 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4B</bold>
###xml 774 781 758 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001032-g004"><bold>Fig. 4B</bold></xref>
###xml 866 873 846 853 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4C</bold>
###xml 866 873 846 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001032-g004"><bold>Fig. 4C</bold></xref>
###xml 1026 1033 1003 1010 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4D</bold>
###xml 1026 1033 1003 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001032-g004"><bold>Fig. 4D</bold></xref>
###xml 91 95 <span type="species:ncbi:727">NTHi</span>
###xml 204 208 <span type="species:ncbi:727">NTHi</span>
###xml 367 371 <span type="species:ncbi:727">NTHi</span>
###xml 393 398 <span type="species:ncbi:9606">human</span>
###xml 697 701 <span type="species:ncbi:727">NTHi</span>
###xml 818 822 <span type="species:ncbi:727">NTHi</span>
###xml 981 985 <span type="species:ncbi:727">NTHi</span>
###xml 1074 1079 <span type="species:ncbi:9606">human</span>
###xml 1240 1244 <span type="species:ncbi:727">NTHi</span>
Having demonstrated the critical role of TLR2-dependent MyD88-TRAF6/7 signaling pathway in NTHi-induced NF-kappaB-dependent inflammatory response, we next sought to determine if CYLD negatively regulates NTHi-induced NF-kappaB activation by targeting TRAF6/7. We initially evaluated the role of CYLD in activation of NF-kappaB and the resultant cytokine induction by NTHi by CYLD knockdown in human middle ear epithelial HMEEC-1 cells. We first confirmed the efficiency of CYLD-specific siRNA (siRNA-CYLD) in reducing CYLD expression. As expected, endogenous CYLD protein was markedly reduced by siRNA (Fig. 4A, upper panel). CYLD knockdown by using siRNA-CYLD enhanced activation of NF-kappaB by NTHi, whereas overexpression of WT-CYLD inhibited it (Fig. 4A, lower panel & Fig. 4B). Moreover, CYLD knockdown enhanced NTHi-induced DNA binding activity of NF-kappaB (Fig. 4C). Consistent with these results, siRNA-CYLD also enhanced the induction of IL-1beta and IL-8 expression by NTHi in middle ear epithelial HMEEC-1 cells (Fig. 4D). Similar results were also observed in human airway epithelial A549 cells and primary airway epithelial NHBE cells (Data not shown). Our data thus suggest that CYLD indeed acts as a negative regulator for NTHi-induced NF-kappaB-dependent inflammatory response in middle ear and respiratory epithelial cells.
###end p 41
###begin title 42
###xml 38 42 <span type="species:ncbi:727">NTHi</span>
CYLD acts as a negative regulator for NTHi-induced NF-kappaB activation via negative cross-talk with TRAF6/7.
###end title 42
###begin p 43
###xml 800 806 773 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p&lt;0.05</italic>
###xml 81 85 <span type="species:ncbi:727">NTHi</span>
###xml 187 191 <span type="species:ncbi:727">NTHi</span>
###xml 257 261 <span type="species:ncbi:727">NTHi</span>
###xml 398 402 <span type="species:ncbi:727">NTHi</span>
###xml 822 826 <span type="species:ncbi:727">NTHi</span>
A. CYLD knockdown by siRNA-CYLD markedly reduced expression of CYLD and enhanced NTHi-induced NF-kappaB-dependent promoter activity in HMEEC cells. B, overexpression of WT-CYLD inhibited NTHi-induced NF-kappaB-dependent promoter activity in HMEEC cells. C, NTHi-induced DNA binding activity of NF-kappaB was enhanced by CYLD knockdown, as assessed by EMSA. D, CYLD knockdown by siRNA-CYLD enhanced NTHi-induced IL-1beta and IL-8 expression at mRNA level in HMEEC-1 cells. E, TRAF7 synergistically enhanced TRAF6-induced NF-kappaB-dependent promoter activity. Overexpression of WT-CYLD inhibited TRAF6- and TRAF7-induced NF-kappaB-dependent promoter activity, whereas CYLD knockdown by siRNA-CYLD enhanced TRAF6- and TRAF7-induced NF-kappaB-dependent promoter activity in lung epithelial A549 cells. *p<0.05, compared with NTHi-inoculated in Mock in A, B and D. Values are means +/- S.D. (n = 3).
###end p 43
###begin p 44
###xml 520 527 500 507 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4E</bold>
###xml 520 527 500 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001032-g004"><bold>Fig. 4E</bold></xref>
###xml 46 50 <span type="species:ncbi:727">NTHi</span>
###xml 223 227 <span type="species:ncbi:727">NTHi</span>
###xml 293 297 <span type="species:ncbi:727">NTHi</span>
We next sought to determine how CYLD inhibits NTHi-induced NF-kappaB activation. We previously showed that TRAF7 cooperates with TRAF6 in mediating NF-kappaB activation. Since we have shown that TRAF6 and 7 are involved in NTHi-induced NF-kappaB activation, it is likely that CYLD may inhibit NTHi-induced NF-kappaB activation by targeting TRAF6 and 7. We first tested our hypothesis by evaluating if CYLD knockdown or overexpressing WT CYLD alters NF-kappaB activation induced by expressing WT TRAF6 and 7. As shown in Fig. 4E, TRAF7 synergistically enhanced TRAF6-induced NF-kappaB activation, and overexpression of WT-CYLD inhibited TRAF6 and 7-induced NF-kappaB activation, whereas CYLD knockdown by siRNA-CYLD enhanced NF-kappaB activation induced by wt-TRAF6 and 7. Our data thus suggests that CYLD inhibits NF-kappaB by targeting TRAF6 and 7.
###end p 44
###begin title 45
CYLD inhibits TRAF6 and TRAF7 in a deubiquitination-dependent manner
###end title 45
###begin p 46
###xml 124 128 124 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Trompouki1">[16]</xref>
###xml 129 133 129 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Kovalenko1">[18]</xref>
###xml 135 139 135 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Yoshida1">[20]</xref>
###xml 291 302 291 302 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 5A &amp; C</bold>
###xml 291 302 291 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001032-g005"><bold>Fig. 5A &amp; C</bold></xref>
###xml 593 604 593 604 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 5B &amp; D</bold>
###xml 593 604 593 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001032-g005"><bold>Fig. 5B &amp; D</bold></xref>
###xml 223 227 <span type="species:ncbi:727">NTHi</span>
###xml 304 308 <span type="species:ncbi:727">NTHi</span>
###xml 648 652 <span type="species:ncbi:727">NTHi</span>
Because CYLD is known as a deubiquitinating enzyme (DUB) and polyubiquitination plays an important role in TRAFs activation [16]-[18], [20], we next determined if CYLD deubiquitinates TRAF6 and 7. We first examined whether NTHi induces polyubiquitination of TRAF6 and TRAF7. As shown in the Fig. 5A & C, NTHi induced polyubiquitination of TRAF6 and TRAF7 in a time-dependent manner, respectively. Moreover, co-expression of WT-CYLD caused a reduction in TRAF6 and TRAF7 ubiquitination, and CYLD knockdown by siRNA-CYLD markedly increased levels of ubiquitinated TRAF6 and TRAF7 in HeLa cells (Fig. 5B & D). Together, we conclude that CYLD inhibits NTHi-induced NF-kappaB-dependent inflammatory response by deubiquitinating TRAF6 and TRAF7.
###end p 46
###begin title 47
CYLD inhibits TRAF6 and TRAF7 in a deubiquitination-dependent manner.
###end title 47
###begin p 48
###xml 3 7 <span type="species:ncbi:727">NTHi</span>
###xml 169 173 <span type="species:ncbi:727">NTHi</span>
A, NTHi induced ubiquitination of TRAF6. B, co-expressing WT-CYLD inhibited, whereas CYLD knockdown by siRNA-CYLD enhanced the ubiquitination of TRAF6 in HeLa cells. C, NTHi induced ubiquitination of TRAF7. D, co-expressing WT-CYLD inhibited, whereas CYLD knockdown by siRNA-CYLD enhanced the ubiquitination of TRAF7 in HeLa cells.
###end p 48
###begin title 49
Discussion
###end title 49
###begin p 50
###xml 175 179 175 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Liew1">[31]</xref>
###xml 548 551 544 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Watanabe1">[6]</xref>
###xml 553 556 549 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Shuto1">[9]</xref>
###xml 558 562 554 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Imasato1">[10]</xref>
###xml 762 765 754 757 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 758 765 750 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tlr2<sup>&#8722;/&#8722;</sup></italic>
###xml 775 778 767 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 770 778 762 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MyD88<sup>+/&#8722;</sup></italic>
###xml 917 923 905 911 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6</bold>
###xml 917 923 905 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001032-g006"><bold>Fig. 6</bold></xref>
###xml 1274 1278 1258 1262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Deng1">[32]</xref>
###xml 1279 1283 1263 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Habelhah1">[36]</xref>
###xml 1470 1474 1454 1458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Fukushima1">[37]</xref>
###xml 130 135 <span type="species:ncbi:9606">human</span>
###xml 289 293 <span type="species:ncbi:727">NTHi</span>
###xml 493 497 <span type="species:ncbi:727">NTHi</span>
###xml 779 783 <span type="species:ncbi:10090">mice</span>
###xml 806 810 <span type="species:ncbi:727">NTHi</span>
###xml 1093 1097 <span type="species:ncbi:727">NTHi</span>
###xml 1527 1531 <span type="species:ncbi:727">NTHi</span>
Negative feedback regulation plays a critical role in preventing overactive and detrimental inflammatory response in a variety of human diseases including infectious diseases [31]. To fully understand the molecular mechanisms underlying the negative regulation of inflammatory response in NTHi infections including otitis media and chronic obstructive pulmonary diseases, it is essential to identify the key receptor-mediated signaling adaptors. We previously showed that TLR2 is required for NTHi-induced NF-kappaB-dependent inflammatory response [6], [9], [10]. However, the key signaling adaptors that link TLR2 with NF-kappaB still remain unknown. In the present study, by overexpressing dominant-negative mutants of TLR2, MyD88 and TRAF6/7 and by using Tlr2-/- and MyD88+/- mice, we demonstrated that NTHi induced NF-kappaB-dependent inflammatory response through TLR2-dependent MyD88-TRAF6/7 signaling pathway (Fig. 6). This finding is of particular interest because disrupting the signaling-mediated by TRAFs, the bottleneck of the receptor-mediated signaling, should efficiently block NTHi-induced TLR2-dependent NF-kappaB activation and the subsequent inflammatory response. Thus, the TRAF6/7 complex appears to be an attractive target for therapeutic intervention [32]-[36]. Indeed, over the past decade significant effort has been put into developing therapeutic strategies to shut down TRAF6 signaling for reducing the mortality associated with septic shock [37]. Since TRAF6/7 complex is essential for transducing NTHi-initiated signal from surface TLR to the NF-kappaB in the nucleus, it would be thus an ideal target for negative feedback regulation in the pathogenesis of bacteria infection.
###end p 50
###begin title 51
###xml 55 59 <span type="species:ncbi:727">NTHi</span>
Schematic representation of the negative regulation of NTHi-induced inflammatory response by CYLD.
###end title 51
###begin p 52
###xml 153 157 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Bignell1">[13]</xref>
###xml 158 162 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-PobleteGutierrez1">[15]</xref>
###xml 164 172 164 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 274 278 266 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Trompouki1">[16]</xref>
###xml 279 283 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Kovalenko1">[18]</xref>
###xml 786 790 778 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Chen1">[38]</xref>
###xml 1115 1122 1103 1110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1122 1126 1110 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Reiley3">[39]</xref>
###xml 1128 1132 1116 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Massoumi1">[40]</xref>
###xml 1194 1201 1182 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1319 1322 1307 1310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1315 1322 1303 1310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyld<sup>&#8722;/&#8722;</sup></italic>
###xml 1424 1427 1412 1415 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1420 1427 1408 1415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyld<sup>&#8722;/&#8722;</sup></italic>
###xml 1434 1440 1422 1428 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1</bold>
###xml 1434 1440 1422 1428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001032-g001"><bold>Fig. 1</bold></xref>
###xml 1602 1609 1590 1597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1640 1647 1628 1635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 118 123 <span type="species:ncbi:9606">human</span>
###xml 964 968 <span type="species:ncbi:727">NTHi</span>
###xml 1323 1327 <span type="species:ncbi:10090">mice</span>
###xml 1355 1359 <span type="species:ncbi:727">NTHi</span>
###xml 1428 1432 <span type="species:ncbi:10090">mice</span>
###xml 1696 1700 <span type="species:ncbi:727">NTHi</span>
###xml 1808 1812 <span type="species:ncbi:10090">mice</span>
The deubiquitinating enzyme CYLD was initially identified as a tumor suppressor because loss of which causes a benign human tumor called cylindromatosis [13]-[15]. In vitro studies indicate that CYLD inhibits TNF-alpha-induced NF-kappaB activation by deubiquitinating TRAF2 [16]-[18]. Ubiquitination is previously known for its role in targeting proteins for degradation by the proteasome, but evidence of the nonproteolytic functions of ubiquitin is also rapidly accumulating. Initial evidence for the regulatory, rather than proteolytic, function of ubiquitin is provided by study of the TRAF proteins, which function as ubiquitin ligases to synthesize lysine 63 (K63)-linked polyubiquitin chains to mediate activation of downstream kinases through a proteasome-independent mechanism [38]. Despite the role of CYLD in inhibiting TRAF2 by deubiquitinating it, its role in deubiquitinating other TRAF family members remains unclear. The role of CYLD in regulating NTHi-induced NF-kappaB activation also remains unknown. Moreover, despite its known role in regulating T-cell development and tumor cell proliferation in vivo[39], [40], its role in regulating inflammation in bacterial infections in vivo is still unclear. In the present study, we have shown that, by performing the inflammatory phenotype analysis of Cyld-/- mice, CYLD negatively regulates NTHi-induced inflammatory response in the middle ear and lung of Cyld-/- mice (Fig. 1), and this negative regulation results in enhanced pathological changes in the middle ear and lung as well as increased expression of pro-inflammatory mediators in vivo. Thus our data provide direct in vivo evidence for the negative regulation of CYLD in NTHi-induced inflammation via a deubiquitination-dependent inhibition of TRAF6/7 in the middle ear and lungs of mice.
###end p 52
###begin p 53
###xml 262 265 262 265 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 258 265 258 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyld<sup>&#8722;/&#8722;</sup></italic>
###xml 326 330 326 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Zhang1">[21]</xref>
###xml 332 336 332 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Massoumi1">[40]</xref>
###xml 381 384 381 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 377 384 377 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyld<sup>&#8722;/&#8722;</sup></italic>
###xml 991 995 991 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Yoshida1">[20]</xref>
###xml 997 1001 997 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001032-Jono1">[23]</xref>
###xml 86 90 <span type="species:ncbi:727">NTHi</span>
###xml 266 270 <span type="species:ncbi:10090">mice</span>
###xml 385 389 <span type="species:ncbi:10090">mice</span>
###xml 760 764 <span type="species:ncbi:727">NTHi</span>
###xml 1120 1124 <span type="species:ncbi:727">NTHi</span>
###xml 1212 1216 <span type="species:ncbi:727">NTHi</span>
In the present study, it is clear that CYLD acts as a critical negative regulator for NTHi-induced inflammation in the middle ear and lung. However, the expression of CYLD in the middle ear and lung is relatively low under physiological condition. Moreover, Cyld-/- mice exhibit no overt abnormalities under normal conditions [21], [40]. Moreover it was recently reported that Cyld-/- mice are more susceptible to chemical-induced skin-tumorigenesis even though they appear normal under physiological condition. These interesting findings thus led us to hypothesize that CYLD, although expressed at relatively low level under physiological conditions, is up-regulated by bacteria during middle ear and lung infection, which in turn leads to the attenuation of NTHi-induced inflammation. In view of CYLD in negative regulation of bacteria-induced TLR2-dependent inflammatory response, it is interesting to note that CYLD expression itself is also regulated by bacteria-induced TLR activation [20], [23]. CYLD is induced rapidly after activation of TLR2 by various bacterial pathogens including PGN, MALP-2, Pam3CSK4, and NTHi. Our finding reveals novel molecular mechanisms by which bacterial pathogens including NTHi induce CYLD expression, which in turn attenuates bacteria-induced inflammatory response. Given that prolonged CYLD expression is anticipated to suppress adequate host response to the invading pathogens, which is necessary for the adequate host defense, it is also of particular interest to investigate how CYLD expression is negatively regulated. This study should provide novel insights into how inflammation is tightly regulated and may lead to the development of novel therapeutic strategies for modulating inflammation.
###end p 53
###begin p 54
We are grateful to Drs. R. Bernards and G. Courtois for kindly providing reagents.
###end p 54
###begin title 55
References
###end title 55
###begin article-title 56
###xml 12 34 <span type="species:ncbi:727">Haemophilus influenzae</span>
Nontypeable Haemophilus influenzae: pathogenesis and prevention.
###end article-title 56
###begin article-title 57
###xml 73 95 <span type="species:ncbi:727">Haemophilus influenzae</span>
Molecular determinants of the pathogenesis of disease due to non-typable Haemophilus influenzae.
###end article-title 57
###begin article-title 58
Chronic obstructive pulmonary disease.
###end article-title 58
###begin article-title 59
###xml 0 22 <span type="species:ncbi:727">Haemophilus influenzae</span>
Haemophilus influenzae in chronic bronchitis.
###end article-title 59
###begin article-title 60
The role of bacteria in airway inflammation in exacerbations of chronic obstructive pulmonary disease.
###end article-title 60
###begin article-title 61
###xml 51 73 <span type="species:ncbi:727">Haemophilus influenzae</span>
Synergistic activation of NF-kappaB by nontypeable Haemophilus influenzae and tumor necrosis factor alpha.
###end article-title 61
###begin article-title 62
Signaling to NF-kappaB.
###end article-title 62
###begin article-title 63
Missing pieces in the NF-kappaB puzzle.
###end article-title 63
###begin article-title 64
Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha/beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells.
###end article-title 64
###begin article-title 65
###xml 99 121 <span type="species:ncbi:727">Haemophilus influenzae</span>
Inhibition of p38 MAPK by glucocorticoids via induction of MAPK phosphatase-1 enhances nontypeable Haemophilus influenzae-induced expression of toll-like receptor 2.
###end article-title 65
###begin article-title 66
Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin.
###end article-title 66
###begin article-title 67
###xml 0 22 <span type="species:ncbi:10298">Herpes simplex virus 1</span>
Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis.
###end article-title 67
###begin article-title 68
Identification of the familial cylindromatosis tumour-suppressor gene.
###end article-title 68
###begin article-title 69
Loss of heterozygosity at cylindromatosis gene locus, CYLD, in sporadic skin adnexal tumours.
###end article-title 69
###begin article-title 70
Phenotype diversity in familial cylindromatosis: a frameshift mutation in the tumor suppressor gene CYLD underlies different tumors of skin appendages.
###end article-title 70
###begin article-title 71
CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.
###end article-title 71
###begin article-title 72
Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB.
###end article-title 72
###begin article-title 73
The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination.
###end article-title 73
###begin article-title 74
Negative regulation of JNK signaling by the tumor suppressor CYLD.
###end article-title 74
###begin article-title 75
The tumor suppressor cylindromatosis (CYLD) acts as a negative regulator for toll-like receptor 2 signaling via negative cross-talk with TRAF6 AND TRAF7.
###end article-title 75
###begin article-title 76
###xml 116 120 <span type="species:ncbi:10090">mice</span>
Impaired regulation of NF-kappaB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice.
###end article-title 76
###begin article-title 77
Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses.
###end article-title 77
###begin article-title 78
NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway.
###end article-title 78
###begin article-title 79
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 80 101 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection.
###end article-title 79
###begin article-title 80
###xml 51 64 <span type="species:ncbi:727">H. influenzae</span>
###xml 69 82 <span type="species:ncbi:2104|species:ncbi:1313">S. pneumoniae</span>
Synergistic activation of NF-kappaB by nontypeable H. influenzae and S. pneumoniae is mediated by CK2, IKKbeta-IkappaBalpha, and p38 MAPK.
###end article-title 80
###begin article-title 81
Glucocorticoids synergize with IL-1beta to induce TLR2 expression via MAP Kinase Phosphatase-1-dependent dual Inhibition of MAPK JNK and p38 in epithelial cells.
###end article-title 81
###begin article-title 82
###xml 95 100 <span type="species:ncbi:9606">human</span>
E-cadherin promotes EGFR-mediated cell differentiation and MUC5AC mucin expression in cultured human airway epithelial cells.
###end article-title 82
###begin article-title 83
The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense.
###end article-title 83
###begin article-title 84
Toll-like receptor signalling.
###end article-title 84
###begin article-title 85
Inferences, questions and possibilities in Toll-like receptor signalling.
###end article-title 85
###begin article-title 86
Negative regulation of toll-like receptor-mediated immune responses.
###end article-title 86
###begin article-title 87
Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain.
###end article-title 87
###begin article-title 88
Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling.
###end article-title 88
###begin article-title 89
Themes and variations on ubiquitylation.
###end article-title 89
###begin article-title 90
Regulatory functions of ubiquitination in the immune system.
###end article-title 90
###begin article-title 91
Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB.
###end article-title 91
###begin article-title 92
Ubiquitin-conjugating enzyme Ubc13 is a critical component of TNF receptor-associated factor (TRAF)-mediated inflammatory responses.
###end article-title 92
###begin article-title 93
Ubiquitin signalling in the NF-kappaB pathway.
###end article-title 93
###begin article-title 94
Regulation of T cell development by the deubiquitinating enzyme CYLD.
###end article-title 94
###begin article-title 95
Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling.
###end article-title 95
###begin p 96
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 96
###begin p 97
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants from National Institute of Health DC004562 and DC005843 to J.D. Li.
###end p 97

